Virus Proves Protective Against Lupus In Mice PDF Print E-mail
Tuesday, 03 April 2012 22:53
A viral infection may help combat lupus. The mouse version of a virus thought to be a prime suspect in the disease, the Epstein-Barr virus, actually prevents certain features of the autoimmune disease, a study in mice shows.

“It might be that this virus has positive effects,” says study author Roberta Pelanda of the National Jewish Health hospital and the University of Colorado Denver School of Medicine. “We really don’t know what these chronic viruses do to the immune system.” Pelanda and her colleagues describe the findings online April 2 in the Proceedings of the National Academy of Sciences.

In people with lupus, the immune system makes antibodies called autoantibodies that attack the body, including the kidneys, heart, skin and blood. While the cause of lupus remains poorly understood, some studies have suggested that the Epstein-Barr virus may trigger the disease in susceptible individuals. The virus, a member of the herpesvirus family, is best known as the cause of mononucleosis. Infection with Epstein-Barr is extremely common, and in most people the virus remains dormant for much of a person’s lifetime.

In the new work, scientists set out to examine the link between Epstein-Barr and the production of autoantibodies in mice. Because Epstein-Barr virus doesn’t actually infect mice, Pelanda and her team used a similar rodent virus, the murine gammaherpesvirus 68, as a stand-in. Analyzing blood samples and the kidneys from lupus-susceptible mice infected with the mouse virus, the team found something unexpected: These animals tended to have healthier, higher-functioning kidneys compared with mice that had not been infected with the virus.

Though levels of autoantibodies rose initially after infection, over the course of a year, lupus-prone female mice tended to make lower levels of autoantibodies compared with noninfected females.

What’s more, healthy mice that were not susceptible to lupus also tended to make low levels of self-attacking antibodies following infection with this virus. These findings suggest that the mouse virus does not trigger autoimmunity.

“The most exciting aspect of this paper is that an infection by a very common virus might be protective from systemic autoimmunity, such as lupus,” says Laurence Morel, a lupus researcher the University of Florida in Gainesville. Though these results are intriguing, she cautions that what’s seen in lab mice might not represent what goes on in humans.

Source: Cheung, R. (2012), "Virus proves protective against lupus in mice", ScienceNews;
 
More articles :

» Cytokines in Systemic Sclerosis: Focus on IL-17

Julie Baraut, Dominique Farge, Elena Ivan-Grigore, Franck Verrecchia, and Laurence MichelSystemic sclerosis (SSc) is an autoimmune disease characterized by progressive sclerosis of the skin and internal organ dysfunction. Cytokine production and...

» The Incidence Of Prostate Cancer Higher In Men With Autoimmune Diseases

Men with autoimmune diseases have a higher incidence of (PCa) than those without those diseases, according to study findings presented at the annual meeting.Using the National Inpatient Sample database, researchers obtained data on 189,290 men...

» Mixed Connective Tissue Disease May Represent Subset of Systemic Scleroderma

Many patients with (MCTD) may represent a subset of Systemic , rather than a disease involving overlapping connective tissue disorders as is commonly believed, or a subset of Lupus as some have suggested over the years, Dr. Virginia Steen said at...

» Vascular Complications of Systemic Sclerosis during Pregnancy

Eliza F. Chakravarty, MD MSSystemic sclerosis (SSc) is a chronic autoimmune disorder characterized by progressive fibrosis of the skin and visceral tissues as well as a non-inflammatory vasculopathy. Vascular disease in systemic sclerosis is a major...

» Could The Drug Gleevec Be The First Possible Treatment For Scleroderma?

Investigators have identified a drug that is currently approved to treat certain types of cancer, , that could provide the first treatment for . The news will be presented at the annual meeting of the on October 18 in Philadelphia. "There has never...

» Primary Biliary Cirrhosis Associated with Systemic Sclerosis: Diagnostic and Clinical Challenges

Cristina Rigamonti, Dimitrios P. Bogdanos, Maria G.Mytilinaiou, Daniel S. Smyk, Eirini I. Rigopoulou, and Andrew K. BurroughsReceived 3 June 2011; Accepted 7 September 2011Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease...